Zobrazeno 1 - 10
of 71
pro vyhledávání: '"R A, Rifkind"'
Publikováno v:
Molecular and Cellular Biology. 10:3535-3540
Hexamethylene bisacetamide (HMBA) is a potent inducer of differentiation of murine erythroleukemia cells (MELC). Commitment, the irreversible initiation of the program of terminal-cell differentiation, is first detected in HMBA-sensitive DS19-SC9 MEL
Autor:
L Z, He, T, Tolentino, P, Grayson, S, Zhong, R P, Warrell, R A, Rifkind, P A, Marks, V M, Richon, P P, Pandolfi
Publikováno v:
The Journal of clinical investigation. 108(9)
Acute promyelocytic leukemia (APL) is associated with chromosomal translocations, invariably involving the retinoic acid receptor alpha (RAR alpha) gene fused to one of several distinct loci, including the PML or PLZF genes, involved in t(15;17) or t
Autor:
D C, Coffey, M C, Kutko, R D, Glick, L M, Butler, G, Heller, R A, Rifkind, P A, Marks, V M, Richon, M P, La Quaglia
Publikováno v:
Cancer research. 61(9)
Histone deacetylase inhibitors (HDACIs) inhibit the growth of a variety of transformed cells in culture. We demonstrated previously that the hybrid-polar HDACI m-carboxycinnamic acid bis-hydroxamide (CBHA) induces apoptosis of human neuroblastoma in
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(4)
Autor:
L M, Butler, Y, Webb, D B, Agus, B, Higgins, T R, Tolentino, M C, Kutko, M P, LaQuaglia, M, Drobnjak, C, Cordon-Cardo, H I, Scher, R, Breslow, V M, Richon, R A, Rifkind, P A, Marks
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(4)
We have synthesized a series of hybrid polar compounds that induce differentiation and/or apoptosis of various transformed cells. These agents are also potent inhibitors of histone deacetylases (HDACs). Pyroxamide (suberoyl-3-aminopyridineamide hydro
Autor:
L M, Butler, D B, Agus, H I, Scher, B, Higgins, A, Rose, C, Cordon-Cardo, H T, Thaler, R A, Rifkind, P A, Marks, V M, Richon
Publikováno v:
Cancer research. 60(18)
Suberoylanilide hydroxamic acid (SAHA) is the prototype of a family of hybrid polar compounds that induce growth arrest in transformed cells and show promise for the treatment of cancer. SAHA induces differentiation and/or apoptosis in certain transf
Publikováno v:
Anticancer research. 19(6B)
Hybrid Polar Cytodifferentiation (HPC) agents represent a novel class of anticancer compounds which act by inducing terminal differentiation and/or apoptosis rather than by cytotoxic action. Among these are HPC agents such as hexamethylenebisacetamid
Autor:
R D, Glick, S L, Swendeman, D C, Coffey, R A, Rifkind, P A, Marks, V M, Richon, M P, La Quaglia
Publikováno v:
Cancer research. 59(17)
Inhibitors of histone deacetylase (HDAC) have been shown to have both apoptotic and differentiating effects on various tumor cells. M-carboxycinnamic acid bishydroxamide (CBHA) is a recently developed hybrid polar compound structurally related to hex
Publikováno v:
Cancer research. 57(13)
Many transformed cells have been found to lose the capacity to proliferate and undergo differentiation following exposure to hybrid polar agents. This study investigates the mechanism by which hexamethylene bisacetamide (HMBA) suppresses the prolifer
Publikováno v:
International journal of hematology. 63(1)
Considerable progress has been made toward elucidating the pathway of induction of terminal differentiation of transformed cells by hybrid polar compounds such as hexamethylene bisacetamide (HMBA). HMBA alters factors controlling G1-to-S phase transi